戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 he pleiotropic protein kinase, CK2 (formerly casein kinase 2).
2 mulation by phosphorylation by CK2 (formerly casein kinase 2).
3 s identified as protein kinase CK2 (formerly casein kinase 2).
4  modulated CSNK2B (the regulatory subunit of casein kinase 2).
5 n synthase kinase-3beta, whereas stimulating casein kinase 2.
6 ing that this phosphorylation is mediated by casein kinase 2.
7 ved sites (Ser712/713) are phosphorylated by casein kinase 2.
8 iated vimentin kinases and identified one as casein kinase 2.
9 ites in the acidic domain of WRN targeted by Casein Kinase 2.
10 t we identified as substrates for Erk1/2 and casein kinase 2.
11 I, whereas Ca(V)1.1-T1579 is a substrate for casein kinase 2.
12 c but not the cardiac CCRK with cyclin H and casein kinase 2.
13 iated by the alpha prime (alpha') subunit of casein kinase 2.
14 es with thapsigargin (10 mum), inhibition of casein kinase 2 (4,5,6,7-tetrabromobenzotriazole; 10 mum
15 overed that murine Arl13b is a substrate for casein kinase 2, a contaminant in our preparation from h
16           Protein kinase CK2 (CK2) (formerly casein kinase 2, a protein Ser/Thr kinase signal that is
17 complex of protein machinery that sequesters casein kinase 2-a Wnt pathway activator.
18 ine 424 by protein kinase CK2 (also known as casein kinase 2) activated the HDAC3 in vitro.
19  of either Galpha(q) or Galpha(o) stimulates casein kinase 2 activation and Lef/Tcf-sensitive gene ex
20 ha(q) or Galpha(o) blocks Wnt stimulation of casein kinase 2 activation, as does suppression of the p
21 ied extracellular regulated kinase 2 blocked casein kinase 2 activity and increased protein serine/th
22          Herein we show to the contrary that casein kinase 2 activity is rapidly and transiently incr
23 minal kinase; (ii) inhibition of calpain and casein kinase 2 activity; and (iii) induction of fibrobl
24                                              Casein kinase 2 alpha phosphorylates PDCD5 at Ser-119 to
25 lation sites and two putative GRIP1 kinases, casein kinase 2 and cyclin-dependent kinase 9.
26  transport in beta-cells that is mediated by casein kinase 2 and PP2B.
27 of which contains a large number of putative casein kinase 2 and protein kinase C phosphorylation sit
28 lation through a dynamic interaction between casein kinase 2 and protein serine/threonine phosphatase
29                                 We show that Casein Kinase 2 and the C-terminal domain Nuclear Envelo
30 molecular events of this modulation involved casein kinase 2 and the synaptic vesicle rapid endocytos
31 s NMDA receptor activity by interacting with casein kinase-2 and protein phosphatases in the hypothal
32                   As in the case of Nopp140, casein kinase 2 appears to be responsible for the unusua
33  has been shown recently to potently inhibit casein kinase 2 as well as PI3K, we hypothesize that cas
34      The amount of Inh2 kinase attributed to casein kinase 2, based on inhibition by heparin, increas
35 ; allograft inflammatory factor 1 (AIF1) and casein kinase 2, beta polypeptide (CSNK2B), all found in
36  levels of [Ca2+]i KHC was phosphorylated by casein kinase 2, but KHC was rapidly dephosphorylated by
37 rf1 mutation led to the discovery of a novel casein Kinase 2 catalytic subunit (CK2alpha").
38 posttranslationally regulated by TNF-induced casein kinase 2 catalytic subunit (CK2alpha') phosphoryl
39                                              Casein kinase 2 catalyzed protein serine/threonine phosp
40 anine nucleotide exchange factor (eIF-2B) by casein kinase 2 (CK-2) was previously shown to stimulate
41 ific inhibitors of casein kinase 1 (CK1) and casein kinase 2 (CK2) (10 muM D4476, 100 muM CK2-inhibit
42 rapeutic potential against TNBC by targeting Casein Kinase 2 (CK2) (PDB ID: 3H30) and ULK2 (Unc-51-li
43 effects of mutant M1 spastins on FAT involve casein kinase 2 (CK2) activation.
44 rt inhibition as a consequence of endogenous casein kinase 2 (CK2) activation.
45 urther, inhibition of claudin-2 by targeting casein kinase 2 (CK2) also ameliorated colitis.
46 ZEBRA, Ser167 and Ser173, are substrates for casein kinase 2 (CK2) and are constitutively phosphoryla
47                                  We focus on casein kinase 2 (CK2) and demonstrate that the regulator
48 to directly associate with and modulate both casein kinase 2 (CK2) and protein kinase A (PKA), which
49  glycerolipid biosynthesis, is stimulated by casein kinase 2 (CK2) and that a phosphorylated protein
50                 This kinase complex contains casein kinase 2 (CK2) and the chromatin transcriptional
51 ified the regulatory (beta) subunit of human casein kinase 2 (CK2) as a CDC34-interacting protein and
52                 In this study, we identified casein kinase 2 (CK2) as a critical modulator of NADPH o
53                                  We identify casein kinase 2 (CK2) as a key regulator of temperature
54                             We also identify casein kinase 2 (CK2) as a kinase activity in embryonic
55                 Previous work has implicated casein kinase 2 (CK2) as the kinase responsible for this
56 ave identified polo-like kinase 1 (Plk1) and casein kinase 2 (CK2) as two kinases of CLIP-170 and map
57 lear condensate; and that phosphorylation by casein kinase 2 (CK2) at ~80 serines targets Nopp140 to
58                                              Casein kinase 2 (CK2) binds to the NHE3 C-terminus and c
59        This protein kinase was identified as casein kinase 2 (CK2) by immunoblot and mass spectrometr
60 e that phosphorylated CD45 was identified as casein kinase 2 (CK2) by use of an in-gel kinase assay i
61 sing Ciona eggs and found that inhibition of casein kinase 2 (CK2) caused a shift from meiotic to mit
62 ormally long circadian periods, we show that casein kinase 2 (CK2) has a role in determining period l
63                                              Casein kinase 2 (CK2) has emerged as a promising therape
64 d for robust in vitro phosphorylation by the casein kinase 2 (CK2) holoenzyme, a cytoplasmic kinase s
65   Residue S583 of SUZ12 is phosphorylated by casein kinase 2 (CK2) in cells.
66  Our previous results highlighted a role for casein kinase 2 (CK2) in the modulation of dopamine D1 r
67     We demonstrate a role for protein kinase casein kinase 2 (CK2) in the phosphorylation and regulat
68 iated stimulation, PTEN is phosphorylated by casein kinase 2 (CK2) in the Ser380-Thr382-Thr383 cluste
69 tified serine 358 as a specific site used by casein kinase 2 (CK2) in vitro and in vivo.
70 A, S167 and S173, that are phosphorylated by casein kinase 2 (CK2) in vitro are also phosphorylated i
71 7 -: tetrabromobenzotriazole (TBB), a potent casein kinase 2 (CK2) inhibitor, as a strong suppressor
72  enhanced by LXR ligands and reduced both by casein kinase 2 (CK2) inhibitors and by activation of it
73 rylation by either protein kinase C (PKC) or casein kinase 2 (CK2) inhibits the assembly of myosin-II
74  beta subunit of the serine/threonine kinase casein kinase 2 (CK2) interacts specifically with the cy
75                                              Casein kinase 2 (CK2) is a multifunctional second messen
76                           The protein kinase casein kinase 2 (CK2) is a pleiotropic and constitutivel
77                                              Casein kinase 2 (CK2) is a typical serine/threonine kina
78 kin (IL)-1 receptor-associated kinase 4, and casein kinase 2 (CK2) is formed.
79                                              Casein kinase 2 (CK2) is known to regulate cell growth a
80                                              Casein kinase 2 (CK2) is oncogenic and frequently upregu
81                      Although protein kinase casein kinase 2 (CK2) is readily detected in MKs and pla
82      Phosphorylation of CBX3 at serine-95 by casein kinase 2 (CK2) kinase augments cadherin 1 (CDH1)-
83              Previous research suggests that casein kinase 2 (CK2) may be a promising therapeutic tar
84     Previous in vitro studies indicated that casein kinase 2 (CK2) mediated the phosphorylation of NS
85                We have previously shown that casein kinase 2 (CK2) negatively regulates dopamine D1 a
86   We demonstrated that increased activity of casein kinase 2 (CK2) observed in HPC and in MDSC could
87 w that murine caspase-9 is phosphorylated by casein kinase 2 (CK2) on a serine near the site of caspa
88 at shock and antioxidants induced Hsp90, and casein kinase 2 (CK2) phosphorylated INrf2Thr55.
89 ay is a key regulator of RUNX2 stability, as Casein kinase 2 (CK2) phosphorylates RUNX2, recruiting t
90                                              Casein kinase 2 (CK2) phosphorylates the NR2B subunit wi
91 ith SUMOylated RNF111, which is regulated by casein kinase 2 (CK2) phosphorylation of ARKL1 at a seri
92 The MRE11-PIH1D1 interaction is dependent on casein kinase 2 (CK2) phosphorylation of two acidic sequ
93     The Foxc2 amino terminus has a consensus casein kinase 2 (CK2) phosphorylation site at serine 124
94      Molecular studies identified the unique casein kinase 2 (CK2) phosphorylation site within isofor
95 ariant of the formin FHOD3 that introduces a casein kinase 2 (CK2) phosphorylation site.
96  the C terminus, which was predicted to be a casein kinase 2 (CK2) phosphorylation site.
97 ) of MDC1, which contains multiple consensus casein kinase 2 (CK2) phosphorylation sites.
98 and overexpression experiments, we show that casein kinase 2 (CK2) promotes stress granule dynamics.
99 that phosphorylation of recombinant TFIIF by casein kinase 2 (CK2) reduces or eliminates some of the
100                                       As the casein kinase 2 (CK2) site at serine 392 is the C-termin
101              We also found that two putative casein kinase 2 (CK2) sites adjacent to IE2-SIM1 are pho
102  serine residues 16 and 18, which are within casein kinase 2 (CK2) sites, and serine residue 114, whi
103 inases with enriched substrates detects that casein kinase 2 (CK2) subunits negatively regulate lifes
104 ctivated through pharmacologic inhibition of casein kinase 2 (CK2) to eradicate disease in high-risk
105 sh1 is phosphorylated by the Cka2 subunit of casein kinase 2 (CK2) to promote its E3 activity for Cse
106                                              Casein kinase 2 (CK2) was one of the first protein kinas
107                                              Casein kinase 2 (CK2) was previously reported to be over
108 he major site of in vitro phosphorylation by casein kinase 2 (CK2) was the conserved Ser(232) in the
109 D025 potently inhibits catalytic subunits of casein kinase 2 (CK2), a constitutively active serine/th
110 ntly shown that the serine/threonine kinase, casein kinase 2 (CK2), a major regulator of cell growth
111                                              Casein Kinase 2 (CK2), a positive regulator of Wnt signa
112                                CD5 activates casein kinase 2 (CK2), a serine/threonine kinase that co
113 ere, we report that Brg1 is also a target of casein kinase 2 (CK2), a serine/threonine kinase, in pro
114 wn previously to require the Cka2 subunit of casein kinase 2 (CK2), a ubiquitous enzyme with multiple
115                                              Casein kinase 2 (CK2), a ubiquitous kinase, regulates se
116                                Inhibition of casein kinase 2 (CK2), an enzyme implicated in DNA damag
117 eral kinases among these proteins, including casein kinase 2 (CK2), and a new bud neck-associated pro
118 nsists of Daz interacting protein 1 (Dzip1), casein kinase 2 (CK2), and B56 containing protein phosph
119 dentify the heterotetrameric protein kinase, casein kinase 2 (CK2), as a new KSR1-binding partner.
120  recovered cDNA revealed a unique isoform of casein kinase 2 (CK2), CK2alpha".
121 on was dependent on XRCC1 phosphorylation by casein kinase 2 (CK2), enhancing XRCC1's interaction wit
122 on events catalyzed first by MEK and then by casein kinase 2 (CK2), followed by interaction with impo
123 s of ATR could be counteracted by inhibiting casein kinase 2 (CK2), the kinase responsible for phosph
124 e, and this phosphorylation was catalyzed by casein kinase 2 (CK2), the levels of which were dramatic
125 1 and Fhl1, Ifh1 forms a complex (CURI) with casein kinase 2 (CK2), Utp22, and Rrp7.
126 -LDH associates with NDPK-A, AMPK alpha1 and casein kinase 2 (CK2), whereas H-LDH associates with loc
127 a striking resemblance to that of eukaryotic casein kinase 2 (CK2), which also exhibits dual nucleoti
128 perone complex and IKK through activation of casein kinase 2 (CK2), which in turn activates NF-kappaB
129 d51 phosphorylation at threonine 13 (T13) by casein kinase 2 (CK2), which in turn triggers direct bin
130 ed up-regulation of the SK channel modulator casein kinase 2 (CK2), which we corroborated by immunohi
131 ulator of Poll III (MAF1), via a synergistic casein kinase 2 (CK2)- and mammalian target of rapamycin
132 es astrocytic protein synthesis and, through casein kinase 2 (CK2)-dependent mechanisms, disrupts the
133                  Wnt stimulation induces the casein kinase 2 (CK2)-dependent phosphorylation of LRP6
134 their spontaneous intrinsic pacemaking via a casein kinase 2 (CK2)-dependent signaling pathway, which
135                      We have also noted that casein kinase 2 (CK2)-directed phosphorylation of Pax7 a
136               In this report, we show that a casein kinase 2 (CK2)-like protein kinase co-purifies wi
137                  Additionally, p17 increases casein kinase 2 (CK2)-mediated phosphorylation, strength
138                              We identified a casein kinase 2 (CK2)-PRMT6-regulator of chromatin conde
139 cal/functional relationship between CD45 and casein kinase 2 (CK2).
140 osphorylated at its N terminus with purified casein kinase 2 (CK2).
141 vity showed it to be identical to Drosophila Casein Kinase 2 (CK2).
142 extremely low concentration of tightly bound casein kinase 2 (CK2).
143  various kinases, including GPCR kinases and casein kinase 2 (CK2).
144  the unsuspected tyrosine kinase activity of casein kinase 2 (CK2).
145 ISA analyses and Western blotting to measure casein kinase 2 (CK2).
146  by the disease-relevant signalling protein, casein kinase 2 (CK2).
147 orylated on conserved serines 487 and 491 by casein kinase 2 (CK2).
148 t human cytomegalovirus pUL84 interacts with casein kinase 2 (CK2).
149 nts indicate that phosphorylation of TLE1 by casein kinase-2 (CK2) at Ser-239 and Ser-253 is necessar
150                                              Casein kinase-2 (CK2) promotes cell survival and is upre
151                                  Conversely, casein kinase-2 (CK2)-inhibitor increases Ikaros functio
152 hibition of one of the catalytic subunits of casein kinase 2, CK2A1, but not CK2A2, improved cell via
153 how that the catalytic subunit of Drosophila casein kinase 2 (CK2alpha) is expressed predominantly in
154 ynthase promoter activity were controlled by casein kinase 2 complexed with protein serine/threonine
155  to mutation to alanine or disruption of the casein kinase 2 consensus sequence directing phosphoryla
156 uired Rab11-dependent trafficking and FAM20C/casein kinase 2-dependent C-terminal phosphorylation of
157 required for insulin induction of Sort1 in a casein kinase 2-dependent manner and that inhibition of
158 B by markedly enhancing GTPCH-1 activity via casein kinase 2-dependent phosphorylation on serine 81.
159  M1-type muscarinic receptors and occur in a casein kinase-2-dependent manner.
160                                          How casein kinase 2 exerts an influence in Wnt signaling is
161  an influence in Wnt signaling is not clear; casein kinase 2 has been reported to be constitutively a
162                                              Casein kinase 2 has been shown to affect Wnt/beta-cateni
163 other kinases; only c-src (IC50, 15 microM), casein kinase 2 (IC50, 20 microM), erk 1 (IC50, 20 micro
164              The serine is phosphorylated by casein kinase 2 in in vitro assays.
165                These data support a role for casein kinase 2 in regulation of protein synthesis by do
166  These findings illustrate a new function of casein kinase 2 in the endothelium and provide insight i
167 inase 2 as well as PI3K, we hypothesize that casein kinase 2 inhibition is responsible for the enhanc
168 in-1, and parkin, whereas treatment with the casein kinase 2 inhibitor 5,6-dichloro-1-beta-d-ribofura
169 on spontaneous release was reproduced by the casein kinase 2 inhibitor 5,6-dichlorobenzimidazole ribo
170 tric-oxide synthase transcription, we used a casein kinase 2 inhibitor coupled with immunoprecipitati
171                                   A clinical casein kinase 2 inhibitor, CX-4945 (silmitasertib), show
172 r localization of Atx3 was not affected by a casein kinase-2 inhibitor or by mutating a predicted nuc
173 he protein phosphatase 1/2A, calcineurin, or casein kinase-2 inhibitor.
174 osphoprotein Dishevelled, demonstrating that casein kinase 2 is downstream of heterotrimeric G protei
175 dues including two serines phosphorylated by casein kinase 2 is required for the localization of VMAT
176                                        Thus, casein kinase 2 is shown to be regulated by Wnt3a and es
177            Protein kinase CK2 (also known as Casein Kinase 2) is a serine/threonine kinase composed o
178                         CK2 (formerly called casein kinase 2) is a ubiquitous messenger-independent s
179 esistance via ZFP91 rewiring, which involves casein kinase 2-mediated c-Jun inactivation.
180                                              Casein kinase 2-mediated phosphorylation at VHL N-termin
181                                 ERK promotes casein kinase 2-mediated phosphorylation of alpha-cateni
182 hin TMVs through a process that requires the casein kinase 2-mediated phosphorylation of RanGAP1.
183                   Furthermore, inhibitors of casein kinase 2 mimicked the effect of phosphatase treat
184                 Protein kinase CK2 (formerly casein kinase 2 or II) is a ubiquitous and highly conser
185                       Chemical inhibition of casein kinase 2 or suppression of its expression blocks
186                          We report here that casein kinase 2 phosphorylates a conserved threonine res
187                   Upon hypertrophic stimuli, casein kinase 2 phosphorylates DPF3a at serine 348.
188                            We also show that casein kinase 2 phosphorylates G3BP1 at serine 149 in vi
189  900 (Ser900) as a unique site of reversible casein kinase 2 phosphorylation in the cytoplasmic domai
190          This mutation introduces a putative casein kinase 2 phosphorylation site in C57BL/6J-A20 not
191 id repeat motifs which exhibit homology with casein kinase 2 phosphorylation sites.
192          Our experiments also disclosed that casein kinase 2 plays an integral role in Tpm phosphoryl
193 ylation of calmodulin by protein kinase CK2 (casein kinase 2) rapidly and reversibly modulated KCNQ2
194 a physical interaction between S6KII and the casein kinase 2 regulatory subunit (CK2beta), suggesting
195     We now show that TFIIF phosphorylated by casein kinase 2 remains competent to support PIC assembl
196 ation of ErbB2 or loss of the betasubunit of casein kinase 2, shifted the whole population toward a f
197 ly, in vitro phosphorylation assays with the casein kinase 2 show that the presence of the basic-leuc
198 sin-IIA heavy chain is phosphorylated on the casein kinase 2 site (S1943).
199             Secretion of DEK is modulated by casein kinase 2, stimulated by interleukin-8, and inhibi
200                                              Casein kinase 2 stimulates the biogenesis of Tom22 and T
201 an interacting protein, protein kinase C and casein kinase 2 substrate in neurons 1 (PACSIN1).
202             The PACSIN (protein kinase C and casein kinase 2 substrate in neurons) adapter proteins c
203                Further, AP-1 contained bound casein kinase-2 that phosphorylated GGA1 and GGA3, there
204            The MSY2 associated kinase is not casein kinase 2, the kinase believed to phosphorylate mR
205                   We show that NS1 redirects casein kinase 2 to activate a phosphatase in the PP2C fa
206            This activity, and the ability of casein kinase 2 to use GTP as a phosphate donor, may be
207 ermore, GSH antagonism of the Ser/Thr kinase casein kinase 2 was by comparison weak (<25%).
208       Some interesting cross reactivity with casein kinase-2 was also identified, and structural feat
209 n FCP1 kinase from HeLa cells and identified casein kinase 2, which, surprisingly, displayed a negati

 
Page Top